All Blue, which owns a 5.9% stake in Zymeworks, in April sent a non-binding acquisition offer after its financing proposal was rejected by the board and then expressed concern about the company's subsequent capital raise.
The board has determined that it would not be appropriate to enter into discussions in response to the current proposal, Zymeworks said.
Zymeworks shares were up 0.7% in recent morning trading Friday.
|Sensata Technologies Sells Qinex Business for $219 M...|
|US Manufacturing Activity Falls More Than Expected i...|
|Mercer International Reduces Pulp Production After F...|
|Update: Micron Technology Fiscal Q3 Adjusted EPS, Re...|
|Insider Sell: McCormick & Co.|